Exam 2: Cardiac Flashcards
Myocardial ischemia is characterized by:
Metabolic O2 demand that exceeds supply
Most common cause of myocardial ischemia:
Narrowing of coronary arteries d/t atherosclerosis
Secondary causes of myocardial ischemia:
HTN or tachycardia (severe) Coronary vasospasm Hypotension (severe) Hypoxia Anemia Aortic insufficiency/stenosis (severe)
Mortality rate of myocardial infarction:
1/3rd
Incidence of myocardial ischemia in surgical patients:
5-10% (estimated)
Major risk factors for myocardial ischemia:
Age (75+) Male ↑LDL Diabetes Hypertension Smoking \+ family hx
Minor risk factors for myocardial ischemia:
Obesity CV disease PVD Menopause Use of estrogen BCPs Sedentary lifestyle High stress/type A personality
Describe how atherosclerosis leads to myocardial damage:
Plaque partially obstructs blood flow
Unstable plaque ruptures/thromboses
Transient ischemia leads to unstable angina; sustained ischemia leads to myocardial infarction/inflammation/necrosis
Effects of sustained ischemia on myocytes:
Stunned/hibernating myocytes
Effects of myocardial infarction/inflammation on myocytes:
Myocardial remodeling
Characteristics of plaques prone to rupture:
Lipid rich core
Thin, fibrous cap
Factors that lead to plaque rupture:
Shear forces
Inflammation
Apoptosis
Macrophage enzymes
Results of plaque rupture:
Inflammation and cytokine release, platelet activation, thrombin production
Thrombus forms over lesion; vasoconstriction of vessel
Results of thrombus formation d/t atherosclerotic plaque rupture:
Acute decrease in coronary blood flow
Unstable angina or myocardial infarction
Cells that infiltrate atherosclerotic plaques:
T cells and macrophages
Six characteristics of rupture-prone plaques:
- T cells in the shoulder region
- Macrophages clustered around T cells
- Thin, fibrous cap
- Lipid rich core
- Newly formed capillaries within the wall
- Lymphocyte/mast cell infiltration
More significant to plaque: size or instability?
Instability
Substances that degrade the collagen plaque cap:
Metalloproteinases
Mechanical stress on plaques maximal at this point:
Junction of fibrous cap and plaque-free vessel wall
Physiologic responses to stress (4):
↑ catecholamines, HR, BP
↓ plasma volume
↑ coronary constriction
↑ platelet activity
Cardiac changes due to physiologic responses to stress (3):
↑ electrical instability
↑ demand
↓ supply
Pathologic effects of stress on cardiac function (4):
VF/VT
Ischemia
Plaque rupture
Coronary thrombosis
Surgical stressors that can impact cardiac function:
Pain
Anxiety
Hypovolemia
Describe stable angina:
No change in precipitating factors for 60+ days
No change in frequency, duration of pain
Describe unstable angina:
Caused by less than normal activity
Prolonged duration
Increasing frequency
Unstable angina signals:
Impending MI
Physiological changes associated with stable angina:
Fixed narrowing: 75% or greater
O2 demand close to normal at baseline
Relieved by rest, reducing demand, or NTG
Physiological changes associated with unstable angina:
Acute plaque changes
Partial thrombosis
Crescendo-ing intensity
↑ frequency, duration, etc
Can cause infarction!
Describe Prinzmetal angina:
Occurs at rest
Coronary spasm
In plaque area or normal vessel
Can be associated with other vasospastic diseases (Reynaud’s)
Define infarction:
Necrosis caused by ischemia
Where and when does infarction occur?
Within 20-30 mins of ischemia
Subendocardial regions
Reaches full size in 3-6 hrs
Size of infarction depends on:
Proximity of lesion
Collateral circulation
Complications of myocardial infarction:
Papillary muscle dysfunction & valvular disease Rupture of infarct Mural thrombi Acute pericarditis Ventricular aneurysm Arrythmias LV failure & pulmonary edema Cardiogenic shock Rupture of wall/septum/papillary muscle Thromboembolism
Describe rupture of myocardial infarct:
Occurs day 4-7
Followed by tamponade and death
Sequelae of mural thrombi:
Stroke
Timing of post-MI pericarditis:
Day 2-4
Most common site for ventricular aneurysm:
Anteroapical region
Incidence of cardiogenic shock post-MI:
10%
Leads which look at LV:
II, V5
Define vascular hypertension:
Diastolic > 90mmHg
Systolic > 140mmHg
Incidence of HTN:
25%
↑ in black pts
HTN is a primary risk factor in:
CAD CVA Cardiac hypertrophy Renal failure Aortic dissection
Causes of HTN:
90-95% idiopathic
5-10% secondary to renal disease
Causes of secondary HTN:
Renal
Endocrine
Cardiovascular
Neurologic
BP = ? x ?
BP = CO x PVR
CO factors that ↑ BP:
Blood volume
Contracility
PVR factors that ↑ BP:
Constrictors/dilators in bloodstream
Neural influences
Local factors
Genetic risk factors for HTN:
Polygenic and heterogenous
Polymorphisms at several different gene loci
Environmental risk factors for HTN:
Stress Obesity Smoking Salt consumption Sedentary lifestyle
Renal theory of HTN:
↓ renal excretion of Na+ leads to ↑ fluid volume/CO
Vasoconstriction d/t autoregulation leads to ↑ BP
Vasoconstriction/hypertrophy theory states that ↑ PVR caused by:
- Factors that induce vasoconstriction (neurogenic, vasoconstrictive agent release, genetic Na+/Ca++ transport defect)
- Stimuli that induce structural ∆s
Causes of secondary HTN:
OCPs (older) Renal parenchymal disease Renin-secreting tumors Aldosteronism Cushing's Pheochromocytoma
Define hypertensive crisis:
Sudden increase in DBP to > 130mmHg
HTN crisis is caused by:
Activation of RAAS
Tx for HTN crisis:
Fast but controlled ↓ in BP with NTP, 0.5-1 μg/kg/min
Monitor UOP, A-line
Bring DBP ↓ to 100-110 over several minutes to hours
Usual cause of mitral stenosis:
Fusion of mitral valve leaflets at commissures d/t rheumatic fever
Mitral valve area < 1 cm2 requires a mean left atrial pressure of:
25mmHg
Left atrial enlargement predisposes the heart to:
Atrial fibrillation
Stasis of blood/formation of thrombi
Symptoms of mitral stenosis:
Dyspnea on exertion when CO ↑
Severe stenosis - CHF
Pathway from mitral stenosis to LV failure:
Mitral stenosis ↓ LA emptying ↑ LA preload ↓ force of LA contraction ↓ delivery of blood to LV ↓ LV output + ↓ O2 supply from pulmonary edema LV failure
Usual cause of isolated aortic stenosis:
Progressive calcification/stenosis of congenitally abnormal valve (bicuspid instead of tricuspid)
Usual cause of aortic stenosis associated with mitral stenosis:
Rheumatic fever
Measurements associated with hemodynamically significant aortic stenosis:
Transvalvular gradient > 50mmHg
Orifice area < 1cm2
Triad of symptoms associated with aortic stenosis:
Angina pectoris (often without ischemic heart disease)
Dyspnea on exertion
Syncope
How does aortic stenosis cause syncope?
↓ SV and flow to brain
What determines compensation for aortic stenosis?
Timing: chronic AS better tolerated than acute stenosis
Effects of aortic stenosis on LV:
Hypertrophy & dilation
Poor pumping ability
Pathway of early atrial stenosis:
Atrial stenosis obstructs LV ejection ↑ pressure in LV ↑ LV mass (hypertrophy) LV compliance ↓ but contractility remains ↑ preload, atrial kick Normal stroke volume
Pathway of late atrial stenosis:
Atrial stenosis obstructs LV ejection ↑ pressure in LV ↑ LV mass (hypertrophy) Fibrosis and ↓ contractility LV dilation ↓ stroke volume
Common cause of mitral regurgitation:
Rheumatic fever (associated with mitral stenosis)
Principle pathologic change produced by mitral regurgitation:
LA volume overload d/t retrograde flow from LV during systole
Mitral regurgitation responsible for ____ wave on PAOP waveform:
V wave
Size of wave correlates to magnitude of regurgitant flow
Ultimate pathological result of mitral regurgitation:
Tricuspid regurgitation
Acute causes of aortic regurgitation:
Infective endocarditis
Trauma
Dissection of thoracic aneurysm
Chronic causes of aortic regurgitation:
Prior rheumatic fever
Persistent systemic hypertension
Changes in heart function with aortic regurgitation:
Regurgitation of part of LV stroke volume from aorta back into ventricle
↓ SV
LV dilation
First organ affected by aortic regurgitation:
Kidneys; RAAS and SNS activation makes s/s worse
Three types of cardiomyopathies:
Dilated
Hypertrophic
Restrictive
Two forms of dilated cardiomyopathy:
Inflammatory
Non-inflammatory
Early s/s of inflammatory myocarditis:
Fatigue
Dyspnea
Palpitations
Typical cause of inflammatory myocarditis:
Infection
Late s/s of inflammatory myocarditis:
CHF
Pulsus alternans
Tachycardia
Pulmonary edema
Prognosis of inflammatory myocarditis:
Usually complete recovery with long-term abx
Causes (5) of non-inflammatory cardiomyopathy:
Toxicity (ETOH) Idiopathic process Degenerative process Infiltrative process (resolved infection) Post-MI necrosis/remodeling
Manifestation of non-inflammatory cardiomyopathy:
CHF
Characteristics (3) of cardiomyopathy-induced heart failure:
Elevated filling pressures
Failure of contractile strength
Inverse relationship between arterial impedance and stroke volume
Describe how dilated cardiomyopathy leads to heart failure:
↓ contractility leads to dilation of the ventricle (to ↑ contractility from stretch on muscle fibers - Frank Starling)
Increased ventricular radius = increased cardiac work and O2 consumption
Cardiac output falls
↑ SNS outflow (renal trigger) in order to ↑ HR/SVR
Stroke volume falls
“Forward failure” presents with:
Fatigue
Hypotension
Oliguria d/t ↓ renal blood flow
“Backward failure” presents with:
Elevated filling pressures required by heart Mitral regurgitation (from dilation of ventricle)
Left sided failure presents with:
Orthopnea
Pulmonary edema
Paroxysmal nocturnal dyspnea
Right sided failure presents with:
Hepatomegaly
JVD
Peripheral edema
Other names for hypertrophic cardiomyopathy:
Idiopathic hypertrophic subaortic stenosis**
Asymmetrical septal hypertrophy
Hypertrophic obstructive cardiomyopathy
Muscular subaortic stenosis
Type of genetic trait that causes hypertrophic cardiomyopathy:
Autosomal dominant
Main defect in hypertrophic cardiomyopathy:
Increase in density of Ca++ channels in contractile elements of heart
Presenting symptom of hypertrophic cardiomyopathy for 50% of patients:
Sudden death or cardiac arrest in 3rd/4th decade
↑ HR during athletic activity means ♥︎ goes into SVT/Vtach
S/s of hypertrophic cardiomyopathy:
Dyspnea, angina, syncope starting in 2nd/3rd decades
Arrhythmia seen with hypertrophic cardiomyopathy:
75% ventricular dysrhythmias
25% SVT
5-10% atrial fibrillation
Annual mortality for hypertrophic cardiomyopathy (overall and post-op):
3-8% overall
1-3% post-op
Portion of the heart that enlarges in hypertrophic cardiomyopathy:
Interventricular septum, typically in top portion below aortic valve
Pathophysiology of hypertrophic cardiomyopathy:
Diastolic dysfunction: cannot fully relax; atrial contribution may be 70% of SV; ↓ SV
Rapid LV ejection d/t overcontractility (80% during early systole!)
Subaortic pressure gradient
Factors that improve systolic function in hypertrophic cardiomyopathy:
Volume loading
Vasoconstriction
Myocardial depression
All factors that impair contractility!
Valvular disease seen in hypertrophic cardiomyopathy:
Mitral regurgitation
Medical management of hypertrophic cardiomyopathy:
Beta blockers
CCBs
Means by which beta blockers help in hypertrophic cardiomyopathy:
Blunts the SNS mediation of subaortic stenosis
Decreases tachyarrythmias
Means by which CCBs help in hypertrophic cardiomyopathy:
Improves diastolic relaxation
Surgical management of hypertrophic cardiomyopathy:
Myomectomy
Echo findings in hypertrophic cardiomyopathy:
Thickened interventricular septum (apex thicker than base)
Poor septal motion
Anterior displacement of mitral valve
Three left-to-right shunt defects:
ASD
VSD
PDA
Cyanosis seen with L to R shunts:
Possible tardive cyanosis, but not seen from outset
Most common heart defect dx’ed in adulthood:
ASD
Development of ASD:
At 4-6 weeks of development
Foramen ovale does not close properly
Clinical features of ASD:
Eventual pulmonary HTN Can reverse into R to L shunt (cyanosis, CHF) Mitral insufficiency (sometimes)
Most common heart defect dx’ed at birth:
VSD
Development of VSD:
Malformation of ventricular septum at 4-8 weeks development
Can close spontaneously in childhood
Clinical features of VSD:
Pulmonary HTN
CHF
Infective endocarditis from blood stasis
PDA closes at birth due to:
↑ O2 level
↓ pulm resistance
↓ prostaglandins (PGE2)
Two R to L shunts:
Tetralogy of Fallot
Transposition of great vessels
Cyanosis seen with R to L shunts:
True cyanosis at birth
Most common cause of cyanotic congenital heart disease:
Tetralogy of Fallot
Four components of tetralogy of Fallot:
- VSD
- Dextraposed (R-shifted) aortic root overriding the VSD
- RV outflow obstruction (narrowing of pulmonary trunk)
- RV hypertrophy
Clinical signs of tetralogy of Fallot:
↓ blood flow to lungs
↑ blood flow to aorta
Manifestations of unrepaired tetralogy of Fallot:
Erythrocytosis ↑ blood viscosity Digital clubbing Infective endocarditis Systemic emboli Brain abscesses
Transposition of the great vessels must be associated with _____ for extrauterine life:
ASD, VSD, PDA - L to R shunts
Clinical feature of transposition of the great vessels:
Cyanosis
Preductal vs. postductal coarctation of the aorta & relative incidence:
Where the narrowing is in relation to the ductus arteriosis
Postductal more common
S/s and treatment of preductal coarctation of the aorta:
Dx in infants
Weak femoral pulses
Cyanosis of lower extremities
CHF
Must be surgically corrected for survival
S/s of postductal coarctation of the aorta:
Dx in older children, young adults Collaterals developed ↓ renal perfusion RAAS activation ↑ pressure in upper extremities, ↓ pressure in lowers Intermittent claudication